Literature DB >> 23714645

Sociodemographic disparities in the treatment of small renal masses.

Andreas Becker1, Florian Roghmann, Quoc-Dien Trinh, Jens Hansen, Zhe Tian, Shahrokh F Shariat, Joachim Noldus, Paul Perrotte, Markus Graefen, Pierre I Karakiewicz, Maxine Sun.   

Abstract

OBJECTIVE: To examine the presence of specific sociodemographic disparities in the treatment of individuals with small renal masses. PATIENTS AND METHODS: Patients diagnosed with pT1aN0M0 renal cell carcinoma (RCC) were identified from the Surveillance, Epidemiology, and End Results database (years 1988-2008). Treatment type was stratified into non-surgical and surgical management and the group of patients who underwent surgical intervention was further stratified into those who underwent partial nephrectomy (PN) and those who underwent radical nephrectomy (RN). The main variables of interest were race and gender, as well as family income and poverty and education levels. Temporal trend analyses and logistic regression models were performed.
RESULTS: Of 26,468 patients with T1aN0M0 RCC, 2797 (10.6%) were non-surgically managed and 23,671 (89.4%) underwent surgery. Of the latter, 14,705 (62.1%) underwent RN and 8966 (37.9%) PN. In multivariable analyses, black patients were 23% more likely to be non-surgically managed than other ethnic groups, and if surgically managed, were 20% less likely to undergo PN (both P ≤ 0.007). Men were 19% more likely than women to be non-surgically managed, but remained 14% more likely to receive a PN (both P < 0.001). Treatment disparities according to income, education and poverty level were recorded. Poverty (odds ratio [OR]: 1.002) and education (OR: 0.998) proxies emerged as important determinants of non-surgical management, whereas income (OR: 1.08, all P ≤ 0.02) was a determinant of PN.
CONCLUSIONS: Social inequalities regarding access to treatment remain prevalent among patients diagnosed with small renal masses. The persistence of such a phenomenon is a concerning trend which merits further investigation.
© 2013 BJU International.

Entities:  

Mesh:

Year:  2013        PMID: 23714645     DOI: 10.1111/bju.12111

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Trends in surgical management of T1 renal cell carcinoma.

Authors:  Jonas Schiffmann; Marco Bianchi; Maxine Sun; Andreas Becker
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

2.  Costs analysis of laparoendoscopic, single-site laparoscopic and open surgery for cT1 renal masses in a European high-volume centre.

Authors:  Giovannalberto Pini; Luigi Ascalone; Francesco Greco; Nasreldin Mohammed; Paolo Fornara
Journal:  World J Urol       Date:  2013-12-18       Impact factor: 4.226

Review 3.  Epidemiology and staging of renal cell carcinoma.

Authors:  Carole A Ridge; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

4.  Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-03-12       Impact factor: 3.498

5.  Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.

Authors:  Michael A Liss; Song Wang; Kerrin Palazzi; Ramzi Jabaji; Nishant Patel; Hak J Lee; J Kellogg Parsons; Ithaar H Derweesh
Journal:  BMC Urol       Date:  2014-12-17       Impact factor: 2.264

6.  Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients.

Authors:  Alejandro Cruz; Faith Dickerson; Kathryn R Pulling; Kyle Garcia; Francine C Gachupin; Chiu-Hsieh Hsu; Juan Chipollini; Benjamin R Lee; Ken Batai
Journal:  Int J Environ Res Public Health       Date:  2022-02-12       Impact factor: 3.390

7.  Treatment and Survival Disparities in the National Cancer Institute's Patterns of Care Study (1987-2017).

Authors:  Dolly C Penn; Melanie Baker; Ann M Geiger; Linda C Harlan
Journal:  Cancer Invest       Date:  2018-08-23       Impact factor: 2.368

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.